UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Why settle for an ancient, analog PBX? The top voice over IP (VoIP) services we've tested deliver enterprise-grade phone system features for a small-business-friendly price. I’ve been writing and ...